Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Chronic Myeloid Leukemia Treatments

32 та иш

  1. THE SIGNIFICANCE OF DRIVER GENE MUTATIONS JAK2, CALR, AND MPL IN CHRONIC MYELOPROLIFERATIVE DISEASES

    Beknur Bobir ugli Giyosov, Kodirjon Tukhtaboevich Boboev, Feruz Asatullaevich Daminov

    МақолаMyeloproliferative Neoplasms: Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  2. Level and Serum Metabolism of Homocysteine in Chronic Myeloid Leukemia Patients: A Literature Review

    K. S. Samarina, Yuliana Yurevna Assesorova, I. V. Berger

    МақолаChronic Myeloid Leukemia TreatmentsClinical oncohematology20260 иқтибос
    ABI

  3. Durable Disease Control in Disseminated Primary Splenic Leiomyosarcoma Treated With Sequential Gemcitabine–Docetaxel and Pazopanib Therapy: A Case Report

    Saida Kurbanova, Biloliddin Sharobiddinov, Oqila Abdusattorova +1

    МақолаGastrointestinal Tumor Research and TreatmentCureus20260 иқтибос
    ABI

  4. Possibilities of Cytogenetic Studies in Acute Myeloid Leukemia (Literature Review)

    Assessorova Yuliana Yurevna, Sadikova Shirin Erimmatovna, Madatov Kurbonboy Aminboevich

    МақолаAcute Myeloid Leukemia ResearchInternational Journal of Medical Science and Public Health Research20260 иқтибос
    ABI

  5. Method Development And Validation For Estimation Of Related Substances In Selpercatinib Bulk Dosage Form By Rp-Hplc Technique

    Mr. Suraj P. Rajurkar, Mr. Salman Ahmad Khan, Mr. Shivprasad Sanjay Dhage +5

    МақолаChronic Myeloid Leukemia TreatmentsInternational Journal of Drug Delivery Technology20260 иқтибос
    ABI

  6. PHARMACOLOGICAL PROPERTIES OF TYROSINE KINASE INHIBITORS: CURRENT PERSPECTIVES

    Kamola Anvarjon kizi Almirzayeva

    МақолаChronic Myeloid Leukemia TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI

  7. PHARMACOLOGICAL PROPERTIES OF TYROSINE KINASE INHIBITORS: CURRENT PERSPECTIVES

    Kamola Anvarjon kizi Almirzayeva

    МақолаChronic Myeloid Leukemia TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 иқтибос
    ABI